Sulfur metabolism as a new therapeutic target of heart failure
Journal of Pharmacological Sciences · 2024
DOI: 10.1016/j.jphs.2024.04.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacological Sciences, 2024. Verfasst von Akiyuki Nishimura und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Physiological Sciences, National Institutes of Natural Sciences (NINS), Okazaki, 444-8787, Japan; Exploratory Research Center …. Hauptthemen laut MEDLINE: Heart Failure, Sulfides, Sulfur, Hydrogen Sulfide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Natural Sciences Exploratory Research Center on Life and Living Systems, JST, Japan Society for the Promotion of Science.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Sulfur-based redox signaling has long attracted attention as critical mechanisms underlying the development of cardiac diseases and resultant heart failure. Especially, post-translational modifications of cysteine (Cys) thiols in proteins mediate oxidative stress-dependent cardiac remodeling including myocardial hypertrophy, senescence, and interstitial fibrosis. However, we recently revealed the existence of Cys persulfides and Cys polysulfides in cells and tissues, which show higher redox activities than Cys and substantially contribute to redox signaling and energy metabolism. We have established simple evaluation methods that can detect polysulfides in proteins and inorganic polysulfides in cells and revealed that polysulfides abundantly expressed in normal hearts are dramatically catabolized by exposure to ischemic/hypoxic and environmental electrophilic stress, which causes vulnerability of the heart to mechanical load. Accumulation of hydrogen sulfide, a nucleophilic catabolite of persulfides/polysulfides, may lead to reductive stress in ischemic hearts, and perturbation of polysulfide catabolism can improve chronic heart failure after myocardial infarction in mice. This review focuses on the (patho)physiological role of sulfur metabolism in hearts, and proposes that sulfur catabolism during ischemic/hypoxic stress has great potential as a new therapeutic strategy for the treatment of ischemic heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute for Physiological Sciences, National Institutes of Natural Sciences (NINS), Okazaki, 444-8787, Japan; Exploratory Research Center on Life and Living Systems, NINS, Okazaki, 444-8787, Japan; SOKENDAI (…
- Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.
Förderung
- National Institutes of Natural Sciences Exploratory Research Center on Life and Living Systems
- JST
- Japan Society for the Promotion of Science
- Government of Japan Ministry of Education Culture Sports Science and Technology
Zitieren
APA
Nishimura, A., Tang, X., Zhou, L., Ito, T., Kato, Y., & Nishida, M. (2024). Sulfur metabolism as a new therapeutic target of heart failure. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2024.04.005
Vancouver
Nishimura A, Tang X, Zhou L, Ito T, Kato Y, Nishida M. Sulfur metabolism as a new therapeutic target of heart failure. Journal of Pharmacological Sciences. 2024. doi:10.1016/j.jphs.2024.04.005
BibTeX
@article{Nishimura2024,
author = {Nishimura, Akiyuki and Tang, Xiaokang and Zhou, Liuchenzi and Ito, Tomoya and Kato, Yuri and Nishida, Motohiro},
title = {Sulfur metabolism as a new therapeutic target of heart failure},
journal = {Journal of Pharmacological Sciences},
year = {2024},
doi = {10.1016/j.jphs.2024.04.005}
}
EUVIMED